Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Association of aspirin resistance with increased stroke severity and infarct size.

Zheng AS, Churilov L, Colley RE, Goh C, Davis SM, Yan B.

JAMA Neurol. 2013 Feb;70(2):208-13. doi: 10.1001/jamaneurol.2013.601.

PMID:
23165316
2.

Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction.

Tei H, Uchiyama S, Usui T.

J Neurol. 2007 Mar;254(3):340-6. Epub 2007 Mar 7.

PMID:
17345045
3.

Aspirin resistance in patients with acute ischemic stroke.

Ozben S, Ozben B, Tanrikulu AM, Ozer F, Ozben T.

J Neurol. 2011 Nov;258(11):1979-86. doi: 10.1007/s00415-011-6052-7. Epub 2011 Apr 21.

PMID:
21509427
4.

Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke.

Buck BH, Liebeskind DS, Saver JL, Bang OY, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Yun SW, Razinia T, Ovbiagele B.

Arch Neurol. 2007 Sep;64(9):1287-91.

PMID:
17846267
5.

Evaluation of initial diffusion-weighted image findings in acute stroke patients using a semiquantitative score.

Morita N, Harada M, Uno M, Matsubara S, Nagahiro S, Nishitani H.

Magn Reson Med Sci. 2009;8(2):47-53.

6.

Insular cortex infarction in acute middle cerebral artery territory stroke: predictor of stroke severity and vascular lesion.

Fink JN, Selim MH, Kumar S, Voetsch B, Fong WC, Caplan LR.

Arch Neurol. 2005 Jul;62(7):1081-5.

PMID:
16009763
7.

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.

Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, Sansing L, Lees KR, Lyden P; SAINT Investigators.

Stroke. 2009 Sep;40(9):3067-72. doi: 10.1161/STROKEAHA.109.554386. Epub 2009 Jul 16.

8.

Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).

Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U.

Stroke. 2007 Jun;38(6):1843-9. Epub 2007 Apr 26.

9.

Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.

Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hoover SL, Alexandrov AV; CLOTBUST Investigators.

J Neuroimaging. 2008 Jan;18(1):56-61. doi: 10.1111/j.1552-6569.2007.00169.x.

PMID:
18190497
10.

Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.

Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC.

Stroke. 1999 Feb;30(2):293-8.

11.

Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction.

Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M.

Arch Neurol. 2005 Jul;62(7):1130-4.

PMID:
16009772
12.

Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion.

Henninger N, Lin E, Baker SP, Wakhloo AK, Takhtani D, Moonis M.

Cerebrovasc Dis. 2012;33(6):525-31. doi: 10.1159/000337335. Epub 2012 Apr 25.

PMID:
22538962
13.

Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy.

Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC; ASAP Investigators.

Stroke. 2009 Jul;40(7):2422-7. doi: 10.1161/STROKEAHA.109.548933. Epub 2009 May 14.

14.

Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke.

Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP.

AJNR Am J Neuroradiol. 2005 Aug;26(7):1789-97.

15.

Aspirin resistance is associated with increased stroke severity and infarct volume.

Oh MS, Yu KH, Lee JH, Jung S, Kim C, Jang MU, Lee J, Lee BC.

Neurology. 2016 May 10;86(19):1808-17. doi: 10.1212/WNL.0000000000002657. Epub 2016 Apr 8.

PMID:
27060166
16.

Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.

Wang Q, Chen C, Chen XY, Han JH, Soo Y, Leung TW, Mok V, Wong KS.

Arch Neurol. 2012 Nov;69(11):1454-60.

PMID:
22893265
17.

FLAIR vascular hyperintensities in acute ICA and MCA infarction: a marker for mismatch and stroke severity?.

Hohenhaus M, Schmidt WU, Brunecker P, Xu C, Hotter B, Rozanski M, Fiebach JB, Jungehülsing GJ.

Cerebrovasc Dis. 2012;34(1):63-9. doi: 10.1159/000339012. Epub 2012 Jun 28.

PMID:
22759720
18.

Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator.

Nighoghossian N, Hermier M, Adeleine P, Derex L, Dugor JF, Philippeau F, Ylmaz H, Honnorat J, Dardel P, Berthezène Y, Froment JC, Trouillas P.

Stroke. 2003 Feb;34(2):458-63.

19.

Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes.

Lyden P, Claesson L, Havstad S, Ashwood T, Lu M.

Arch Neurol. 2004 Nov;61(11):1677-80.

PMID:
15534178
20.

Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.

Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, González MA, Monasterio J.

Stroke. 2001 Aug;32(8):1759-66.

Items per page

Supplemental Content

Write to the Help Desk